Citigroup’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.04M Sell
78,110
-236,343
-75% -$3.42M ﹤0.01% 3286
2026
Q2
$4.68M Buy
314,453
+279,216
+792% +$3.01M ﹤0.01% 2201
2026
Q1
$298K Buy
35,237
+6,112
+21% +$66.9K ﹤0.01% 3802
2025
Q4
$329K Buy
29,125
+14,163
+95% +$175K ﹤0.01% 3773
2025
Q3
$225K Sell
14,962
-215,669
-94% -$3.14M ﹤0.01% 3947
2025
Q2
$3.25M Sell
230,631
-40,365
-15% -$719K ﹤0.01% 2262
2025
Q1
$6.51M Buy
270,996
+77,236
+40% +$2.72M ﹤0.01% 1677
2024
Q4
$7.24M Buy
193,760
+73,855
+62% +$3.45M ﹤0.01% 1631
2024
Q3
$5.99M Buy
119,905
+66,801
+126% +$2.6M ﹤0.01% 1700
2024
Q2
$1.84M Sell
53,104
-112,396
-68% -$4.44M ﹤0.01% 2418
2024
Q1
$9.05M Buy
165,500
+50,747
+44% +$2.51M 0.01% 1310
2023
Q4
$4.91M Sell
114,753
-32,154
-22% -$1000K ﹤0.01% 1609
2023
Q3
$3.82M Buy
146,907
+72,673
+98% +$1.51M ﹤0.01% 1573
2023
Q2
$1.78M Sell
74,234
-214,121
-74% -$3.69M ﹤0.01% 2326
2023
Q1
$3.94M Buy
288,355
+125,878
+77% +$2M ﹤0.01% 1623
2022
Q4
$2.26M Buy
162,477
+19,260
+13% +$272K ﹤0.01% 1946
2022
Q3
$882K Buy
+143,217
New +$1.04M ﹤0.01% 2819

Other funds holding BHVN

Citigroup's BHVN Position: Q3 2026 in Review

Citigroup reduced its Biohaven (BHVN) stake by 75% in Q3 2026, selling an estimated $3.42M and leaving 78,110 shares worth $1.04M. The position accounts for ﹤0.01% of the portfolio, ranked #3286.

Citigroup first reported a position in BHVN in Q3 2022 and has held it in 17 quarters since. The position peaked at $9.05M in Q1 2024. 86 funds tracked by Wall St. Rank hold BHVN as of Q3 2026.

  • Citigroup held 78,110 shares of Biohaven worth $1.04M as of Q3 2026.
  • Citigroup sold 236,343 Biohaven shares in Q3 2026, an estimated $3.42M.
  • Biohaven made up ﹤0.01% of Citigroup's portfolio in Q3 2026, its #3286 holding.
  • Citigroup first reported a position in Biohaven in Q3 2022 and has held it in 17 quarters since.
  • Citigroup's Biohaven position peaked at $9.05M in Q1 2024.
  • 86 funds tracked by Wall St. Rank held Biohaven as of Q3 2026.

Based on Citigroup's 13F filing for Q3 2026, filed 4 Nov 2026.